- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02444325
Diabetes Group Prenatal Care
January 3, 2018 updated by: Washington University School of Medicine
Group Prenatal Care for Women With Diabetes: A Pilot Randomized Control Trial
The investigators primary objective is to conduct a pilot randomized trial to determine the effect of group prenatal care on self-care activities in women with diabetes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Long term, the investigators aim to test the central hypothesis that group prenatal care, compared to traditional prenatal care, will improve glycemic control and, ultimately, maternal and neonatal outcomes in women with type 2 and gestational diabetes.
The objective of this proposal is to conduct a pilot randomized trial to determine the effect of group prenatal care on self-care activities, which have been associated with improved glycemic control, in women with diabetes.
Study Type
Interventional
Enrollment (Actual)
84
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Denver, Colorado, United States, 80204
- Denver Health
-
-
Missouri
-
Saint Louis, Missouri, United States, 63110
- Washington University in St. Louis
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- English (WUMC) or Spanish speaking (DH)
- Type 2 White's Class B diabetes OR gestational diabetes diagnosed by 2-step method < 32 weeks
- Ability to attend group prenatal visit at specified days and times
- Willingness to be randomized
- Randomization at 22 weeks 0 days-32 weeks 0 days
- Ability to give informed consent
Exclusion Criteria:
- Multiple gestation
- Major fetal anomaly
- Serious medical co-morbidity necessitating more care than can be safely provided in group setting, as deemed by medical provider
- Serious psychiatric illness including schizophrenia necessitating more care than can safely be provided in group setting, as deemed by medical provider
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Routine Prenatal Care
Subjects randomized to routine care will receive their care in the usual diabetic clinic attended by residents and faculty.
They will receive consultation with the diabetes educator at diagnosis and as needed.
Patients are seen every 2 weeks (or more by provider discretion) until 37 weeks and weekly until delivery.
Visits are 10-15 minutes and focus on routine screening tests and review of blood sugar logs/medication titration.
Each subject's medical chart will be reviewed for demographics, antenatal management, maternal and neonatal outcomes.
|
|
Experimental: Group prenatal care
Group visits will be held every 2 weeks in a continuous cycle through a four session curriculum.
Women will have weekly visits beginning at 37 weeks with traditional prenatal visits on the weeks when the group does not meet.
Groups of 4-12 women will meet for two hour visits and much of that time will be spent on pregnancy, behavioral health, diabetes and nutrition education.
Groups will be co-facilitated by 2 CenteringPregnancy trained providers at each site and an obstetric provider.
Women may be instructed to have additional visits in the traditional clinic at the discretion of the obstetric provider.
|
Women will receive their prenatal care in a group rather than in the 1:1 traditional manner.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
effect of group prenatal care on maternal diabetes self-care activities as measured Diabetes Self-Care Activities Measure
Time Frame: 37-39 weeks gestation
|
Determine the effect of group prenatal care on maternal diabetes self-care activities as measured by the Diabetes Self-care Activities Measure and confirmed by percentage of recommended blood glucose values completed on logs since initial study visit.
|
37-39 weeks gestation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
effect of group prenatal care on perinatal mood as measured by Edinburgh Postnatal Depression Scale
Time Frame: baseline and 4-12 weeks postpartum
|
Determine the effect of group prenatal care on perinatal mood as measured by the Edinburgh Postnatal Depression Scale
|
baseline and 4-12 weeks postpartum
|
effect of group prenatal care on perceived social support as assessed by the Social Support Scale
Time Frame: 37-39 weeks
|
Determine the effect of group prenatal care on perceived social support through the Social Support Scale
|
37-39 weeks
|
Birthweight
Time Frame: delivery admission
|
Determine the effect of group prenatal care on birthweight
|
delivery admission
|
Gestational age at delivery
Time Frame: delivery admission
|
Determine the effect of group prenatal care on preterm delivery
|
delivery admission
|
Mean 3rd trimester fasting blood glucose
Time Frame: baseline through delivery
|
Determine the effect of group prenatal care on maternal glycemic control through mean 3rd trimester fasting glucose
|
baseline through delivery
|
Breastfeeding
Time Frame: 4-12 weeks postpartum
|
Determine the effect of group prenatal care on initiating breastfeeding
|
4-12 weeks postpartum
|
Contraception
Time Frame: 4-12 weeks postpartum
|
Determine the effect of group prenatal care on initiating contraception
|
4-12 weeks postpartum
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Study Director: Methodius G Tuuli, MD, MPH, Assistant Professor, Washington University in St. Louis
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2015
Primary Completion (Actual)
July 6, 2017
Study Completion (Actual)
September 27, 2017
Study Registration Dates
First Submitted
April 27, 2015
First Submitted That Met QC Criteria
May 13, 2015
First Posted (Estimate)
May 14, 2015
Study Record Updates
Last Update Posted (Actual)
January 5, 2018
Last Update Submitted That Met QC Criteria
January 3, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201503174
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
-
University Hospital, ToursCompleted
-
Technische Universität DresdenWithdrawnPregnancy Trimester, Second | Pregnancy Trimester, First | Pregnancy Trimester, ThirdGermany
-
Hopital Antoine BeclereUnknown
-
Universitair Ziekenhuis BrusselMerck Serono International SAUnknownPregnancy | Pregnancy LossBelgium
-
Turku University HospitalUniversity of TurkuCompleted
Clinical Trials on Group prenatal care
-
Yale UniversityUnited Health FoundationCompletedSexually Transmitted Diseases | Premature Birth | Pregnancy | Infant, Low Birth Weight | Postpartum PeriodUnited States
-
Meir Medical CenterCompleted
-
University of California, San FranciscoPatient-Centered Outcomes Research Institute; California State University,...RecruitingPremature Birth | Depression, Postpartum | Satisfaction, Patient | Depression, Anxiety | Pregnancy Preterm | Prenatal Stress | Health Problems in PregnancyUnited States
-
Washington University School of MedicineActive, not recruitingPregnancy | Type 2 Diabetes | Gestational DiabetesUnited States
-
Washington University School of MedicineEnrolling by invitation
-
Washington University School of MedicineEnrolling by invitationElevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care (EleVATE GC)Pregnancy Related | Perinatal DepressionUnited States
-
Yale UniversityBrown UniversityCompleted
-
Penn State UniversityNational Heart, Lung, and Blood Institute (NHLBI); Arizona State UniversityCompletedPhysical Activity | Overweight and Obesity | Eating Behavior | Weight Change, BodyUnited States
-
Oswaldo Cruz FoundationMontefiore Medical CenterUnknown
-
University of Kansas Medical CenterCompleted